Green Cross Medical Science Corporation (142280) — Cash Flow-to-Debt Ratio
Green Cross Medical Science Corporation (142280) has a Cash Flow-to-Debt Ratio of 0.11x as of December 2025, meaning its operating cash flow of ₩5.01 Billion could theoretically repay 0% of its total liabilities (₩44.14 Billion) in one year. See 142280 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Green Cross Medical Science Corporation Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Green Cross Medical Science Corporation across 12 annual periods. Also explore 142280 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Green Cross Medical Science Corporation (2014–2025)
Year-by-year debt coverage analysis for Green Cross Medical Science Corporation. For market capitalisation and broader financial context, see 142280 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | ₩7.20 Billion | ₩44.14 Billion | ▲ +108.2% |
| 2024 | 0.08x | ₩3.66 Billion | ₩46.76 Billion | ▼ -1.0% |
| 2023 | 0.08x | ₩4.24 Billion | ₩53.61 Billion | ▼ -54.0% |
| 2022 | 0.17x | ₩10.88 Billion | ₩63.22 Billion | ▲ +156.3% |
| 2021 | -0.31x | ₩-18.20 Billion | ₩59.51 Billion | ▼ -71.5% |
| 2020 | -0.18x | ₩-8.76 Billion | ₩49.14 Billion | ▼ -70.5% |
| 2019 | -0.10x | ₩-4.11 Billion | ₩39.29 Billion | ▼ -884.2% |
| 2018 | -0.01x | ₩-516.61 Million | ₩48.63 Billion | ▼ -112.8% |
| 2017 | 0.08x | ₩3.11 Billion | ₩37.31 Billion | ▼ -70.1% |
| 2016 | 0.28x | ₩10.25 Billion | ₩36.76 Billion | ▲ +323.9% |
| 2015 | -0.12x | ₩-5.45 Billion | ₩43.74 Billion | ▼ -15.6% |
| 2014 | -0.11x | ₩-2.22 Billion | ₩20.60 Billion | — |